Melanotan II Research for Sexual Dysfunction
An evidence-based overview of research examining Melanotan II in the context of sexual dysfunction. This page synthesizes findings from peer-reviewed literature.
Research Summary
Melanotan II produces erectile effects as a side effect of its melanocortin receptor activity. This led to the development of PT-141 (bremelanotide), a derivative specifically targeting sexual function. The sexual effects are mediated through melanocortin-4 receptors in the brain affecting sexual motivation and arousal. These effects were unexpected findings during tanning research. Melanotan II is not approved for sexual dysfunction. PT-141, the selective derivative, received FDA approval for female HSDD but not male ED.
Referenced Studies
Click any PMID to view the full study on PubMed.
Other Peptides Studied for Sexual Dysfunction
Important Disclaimer
This page summarizes research findings and does not constitute medical advice. Melanotan II may have regulatory approval for some indications but should only be used under qualified medical supervision. Always consult a healthcare provider before making health decisions.